Ketolide News
Ketek Safety Concerns Persist
For months, there have been growing concerns over the safety of Ketek, an antibiotic that has caused liver failure in a number of patients. Ketek (telithromycin) is part of the ketolide class of antibiotics, and was approved by...
Public Communication - Health Canada Endorsed Important Safety Information on Ketek(telithromycin)
Sanofi-aventis Canada Inc., in consultation with Health Canada, would like to inform Canadian consumers of important new changes regarding the antibiotic KETEK(R) (telithromycin).
FDA Announces Label and Indication Changes for the Antibiotic Ketek
The Food and Drug Administration (FDA) today announced revisions to the labeling for the antibiotic Ketek (telithromycin) designed to improve the safe use of Ketek by patients.
First Quarter 2006 Product Candidate Highlights
Advanced Life Sciences is developing cethromycin, a novel once-a-day ketolide antibiotic in response to the emerging antibiotic resistance observed in the treatment of community acquired pneumonia (CAP).
FDA Warns of Liver Failure With Telithromycin
The warning, which Ketek’s manufacturer is adding to the drug’s labeling, results from FDA’s vigilant monitoring of all drugs after their introduction to the market.